跳至主要内容
临床试验/CTRI/2024/08/072710
CTRI/2024/08/072710尚未招募不适用

Efficacy of dolutegravir based antiretroviral regimen in HIV positive children

Department of Paediatrics1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2024年9月24日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
75
试验地点
1
主要终点
Proportion of patients having viral suppression after 6 months of treatment with Dolutegravir based regimen.

研究概览

简要总结

This study is an observational study aimed at finding the efficacy of Dolutegravir based antiretroviral regimen in HIV positive children aged between 1 month to 15 years. Study will be conducted in Paediatric HIV clinic, Maulana Azad Medical College and associated Lok Nayak Hospital, Delhi.

Primary outcome of the study will be the proportion of patients having viral suppression after 6 months of treatment with Dolutegravir based regimen.

Secondary outcomes of the study will be:

  1. Proportion of patients having adverse events (if any) following treatment with Dolutegravir based regimen and grading of the severity of adverse events.

  2. Proportion of patients adherent to treatment with Dolutegravir based regimen.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Month(s) 至 15.00 Year(s)(—)
性别
All

入选标准

  • Patients substituted to Dolutegravir based regimen from older treatment regimens.
  • Newly diagnosed HIV positive children started on DTG regimen.

排除标准

  • Coinfection with Tuberculosis, Hepatitis B and Hepatitis C.
  • Patients with chronic liver disease and auto immune diseases.

结局指标

主要结局

Proportion of patients having viral suppression after 6 months of treatment with Dolutegravir based regimen.

时间窗: 6 months

次要结局

  • 1. Proportion of patients having adverse events (if any) following treatment with dolutegravir based regimen and grading of severity of adverse events.(2. Proportion of patients adherent to treatment with Dolutegravir based regimen.)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Vijaya lakshmi Minumanuri

Maulana Azad Medical College

研究点 (1)

Loading locations...

相似试验

Efficiency of dolutegravir in treatment of HIV... | 临床试验